KDNA maintains required registrations/licenses including New York, California, FDA, CTO and more. Inquire at firstname.lastname@example.org for current listing
Our tissue safety program includes the following features:
- Rigid donor screening process including a thorough review of the donor’s medical and social history by personnel with advanced Microbiology training and final determination performed by KDNA’s Medical Director
- Recovery of all musculoskeletal tissue is performed utilizing zone recovery and sequencing techniques, under aseptic conditions
- Comprehensive serologic studies are performed meeting the requirements of the FDA
- All allografts are manufactured with strict aseptic processing in ISO Class 6 rooms in Belgrade, MT, USA. All grafts are terminally irradiated.